Publications

Detailed Information

Partial role of TLR4 as a receptor responding to damage-associated molecular pattern

DC Field Value Language
dc.contributor.authorLee, Kyung-Mi-
dc.contributor.authorSeong, Seung-Yong-
dc.date.accessioned2012-06-11T02:32:54Z-
dc.date.available2012-06-11T02:32:54Z-
dc.date.issued2009-06-30-
dc.identifier.citationIMMUNOLOGY LETTERS; Vol.125 1; 31-39ko_KR
dc.identifier.issn0165-2478-
dc.identifier.urihttps://hdl.handle.net/10371/76949-
dc.description.abstractPart of pathogen-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP) activate antigen-presenting cells through Toll-like receptors (TLRs) to initiate immune responses. However, controversy remains if TLR4 mediates DAMP signaling due to the confounding effects of potential LPS contamination. To test if TLR4 functions as a true receptor for DAMP, we compared TLR4(pos)- and TLR4(neg)-responders in vitro and in vivo after stimulation with whole necrotic cell (NC) lysates. Using CHO reporter cells transfected with anti-TLR4-siRNAs, TLR4 was found to partially mediate NF-kappa B activation in response to NC lysates. TLR4(neg) DCs exhibited less I-A(b) expression and nitric oxide secretion than TLR4(pos) DCs upon NC stimulation and this defect was well correlated with diminished presentation of H-Y antigen by TLR4(neg) DCs to I-A(b)-restricted CD4(pos) Marilyn T cells in vitro. Similarly, TLR4(neg) DCs showed significantly less expression of I-A(b), CD80, CD86, and CD40 than TLR4(pos) DCs when NC lysates were injected into peritoneal cavity. Finally, delayed type hypersensitivity response to OVA was significantly decreased in TLR4(neg) mice when NCs were used as an adjuvant. Taken together, our data support the idea that part of the endogenous ligands presented by NCs could activate APCs thru TLR4 and contribute to the development of antigen-specific adaptive immunity. Therefore, endogenous DAMP ligands themselves, not contaminated LPS, activate TLR4 signaling leading to activation of professional antigen-presenting cells.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectToll-like receptorko_KR
dc.subjectPAMPko_KR
dc.subjectDAMPko_KR
dc.subjectInflammationko_KR
dc.subjectNF-κBko_KR
dc.subjectNecrotic cellsko_KR
dc.subjectDendritic cellsko_KR
dc.titlePartial role of TLR4 as a receptor responding to damage-associated molecular patternko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이경미-
dc.contributor.AlternativeAuthor성승용-
dc.identifier.doi10.1016/j.imlet.2009.05.006-
dc.citation.journaltitleIMMUNOLOGY LETTERS-
dc.description.citedreferenceSANCHO D, 2009, NATURE-
dc.description.citedreferenceLehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008-
dc.description.citedreferenceMartinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362-
dc.description.citedreferenceYANG YG, 2007, IEEE POTENTIALS, V26, P26-
dc.description.citedreferenceScheibner KA, 2006, J IMMUNOL, V177, P1272-
dc.description.citedreferenceKaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023-
dc.description.citedreferenceBabu S, 2006, J IMMUNOL, V176, P3885-
dc.description.citedreferenceO`Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012-
dc.description.citedreferenceBarrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914-
dc.description.citedreferenceGeisler F, 2005, J IMMUNOL, V174, P6431-
dc.description.citedreferenceLangelaar MFM, 2005, SCAND J IMMUNOL, V61, P242, DOI 10.1111/j.1365-3083.2005.01559.x-
dc.description.citedreferenceADINOLFI E, 2005, PURINERG SIGNAL, V1, P219-
dc.description.citedreferenceTsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127-
dc.description.citedreferenceSeong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372-
dc.description.citedreferenceWerling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1046/j.1365-2567.2003.01781.x-
dc.description.citedreferenceShi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991-
dc.description.citedreferencePasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231-
dc.description.citedreferenceTakeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126-
dc.description.citedreferenceXu WM, 2002, CELL RES, V12, P311-
dc.description.citedreferenceBausinger H, 2002, EUR J IMMUNOL, V32, P3708-
dc.description.citedreferenceBeg AA, 2002, TRENDS IMMUNOL, V23, P509-
dc.description.citedreferenceJaneway CA, 2002, ANNU REV IMMUNOL, V20, P197-
dc.description.citedreferencePersing DH, 2002, TRENDS MICROBIOL, V10, pS32-
dc.description.citedreferenceMedvedev AE, 2001, J IMMUNOL, V167, P2257-
dc.description.citedreferenceLi M, 2001, J IMMUNOL, V166, P7128-
dc.description.citedreferenceGallucci S, 1999, NAT MED, V5, P1249-
dc.description.citedreferenceBrightbill HD, 1999, SCIENCE, V285, P732-
dc.description.citedreferenceMedzhitov R, 1997, NATURE, V388, P394-
dc.description.citedreferenceMATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991-
dc.description.citedreferenceJANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1-
dc.description.tc6-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share